High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma-Reference-Cited by-同舟云学术

High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma

Published:2008-09-15 Issue:6 Volume:113 Page:1344-1350
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Gopal Ajay K.,Metcalfe Tracee L.,Gooley Ted A.,Pagel John M.,Petersdorf Stephen H.,Bensinger William I.,Holmberg Leona,Maloney David G.,Press Oliver W.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. An update on the management of relapsed and primary refractory Hodgkin's disease;Moskowitz;Semin Oncol.,2004

2. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease;Hasenclever;N Engl J Med.,1998

3. Cancer statistics, 2005;Jemal;CA Cancer J Clin.,2005

4. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure;Longo;J Clin Oncol.,1992

5. Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease;Santaro;Ann Intern Med.,1982

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity;Frontiers in Immunology;2023-08-14

2. Autologous hematopoietic stem cell transplantation in children with relapsed or refractory Hodgkin lymphoma;Pediatric Hematology/Oncology and Immunopathology;2022-06-23

3. Current salvage therapies in Hodgkin lymphoma;Leukemia & Lymphoma;2022-01-17

4. Hodgkin lymphoma;Nature Reviews Disease Primers;2020-07-23

5. Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group);Annals of Oncology;2019-04